DK1474690T3 - E2-forskydningsassay til identifikation af inhibitorer af HPV - Google Patents
E2-forskydningsassay til identifikation af inhibitorer af HPVInfo
- Publication number
- DK1474690T3 DK1474690T3 DK03700788.7T DK03700788T DK1474690T3 DK 1474690 T3 DK1474690 T3 DK 1474690T3 DK 03700788 T DK03700788 T DK 03700788T DK 1474690 T3 DK1474690 T3 DK 1474690T3
- Authority
- DK
- Denmark
- Prior art keywords
- probe
- signal
- hpv
- fluorescence
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35571102P | 2002-02-07 | 2002-02-07 | |
PCT/CA2003/000155 WO2003067259A1 (en) | 2002-02-07 | 2003-02-04 | E2 displacement assay for identifying inhibitors of hpv |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1474690T3 true DK1474690T3 (da) | 2011-01-10 |
Family
ID=27734553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03700788.7T DK1474690T3 (da) | 2002-02-07 | 2003-02-04 | E2-forskydningsassay til identifikation af inhibitorer af HPV |
Country Status (12)
Country | Link |
---|---|
US (1) | US6825176B2 (da) |
EP (1) | EP1474690B1 (da) |
JP (1) | JP2005517183A (da) |
AT (1) | ATE484751T1 (da) |
AU (1) | AU2003202390A1 (da) |
CA (1) | CA2474205C (da) |
DE (1) | DE60334524D1 (da) |
DK (1) | DK1474690T3 (da) |
ES (1) | ES2352332T3 (da) |
MX (1) | MXPA04007705A (da) |
NZ (1) | NZ535051A (da) |
WO (1) | WO2003067259A1 (da) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4859399A (en) * | 1998-07-02 | 2000-01-24 | President And Fellows Of Harvard College | Compositions and methods for treating papillomavirus-infected cells |
US7914453B2 (en) | 2000-12-28 | 2011-03-29 | Ardent Sound, Inc. | Visual imaging system for ultrasonic probe |
US7824348B2 (en) | 2004-09-16 | 2010-11-02 | Guided Therapy Systems, L.L.C. | System and method for variable depth ultrasound treatment |
US10864385B2 (en) | 2004-09-24 | 2020-12-15 | Guided Therapy Systems, Llc | Rejuvenating skin by heating tissue for cosmetic treatment of the face and body |
US8444562B2 (en) | 2004-10-06 | 2013-05-21 | Guided Therapy Systems, Llc | System and method for treating muscle, tendon, ligament and cartilage tissue |
US8535228B2 (en) | 2004-10-06 | 2013-09-17 | Guided Therapy Systems, Llc | Method and system for noninvasive face lifts and deep tissue tightening |
US8690778B2 (en) | 2004-10-06 | 2014-04-08 | Guided Therapy Systems, Llc | Energy-based tissue tightening |
US20060111744A1 (en) | 2004-10-13 | 2006-05-25 | Guided Therapy Systems, L.L.C. | Method and system for treatment of sweat glands |
US9694212B2 (en) | 2004-10-06 | 2017-07-04 | Guided Therapy Systems, Llc | Method and system for ultrasound treatment of skin |
US9827449B2 (en) | 2004-10-06 | 2017-11-28 | Guided Therapy Systems, L.L.C. | Systems for treating skin laxity |
US11883688B2 (en) | 2004-10-06 | 2024-01-30 | Guided Therapy Systems, Llc | Energy based fat reduction |
US8133180B2 (en) | 2004-10-06 | 2012-03-13 | Guided Therapy Systems, L.L.C. | Method and system for treating cellulite |
US7758524B2 (en) | 2004-10-06 | 2010-07-20 | Guided Therapy Systems, L.L.C. | Method and system for ultra-high frequency ultrasound treatment |
US11235179B2 (en) | 2004-10-06 | 2022-02-01 | Guided Therapy Systems, Llc | Energy based skin gland treatment |
US11207548B2 (en) | 2004-10-07 | 2021-12-28 | Guided Therapy Systems, L.L.C. | Ultrasound probe for treating skin laxity |
US11724133B2 (en) | 2004-10-07 | 2023-08-15 | Guided Therapy Systems, Llc | Ultrasound probe for treatment of skin |
EP1875327A2 (en) | 2005-04-25 | 2008-01-09 | Guided Therapy Systems, L.L.C. | Method and system for enhancing computer peripheral saftey |
KR20110020293A (ko) | 2008-06-06 | 2011-03-02 | 얼테라, 인크 | 코스메틱 치료 및 이미징 시스템 및 방법 |
CA2748362A1 (en) | 2008-12-24 | 2010-07-01 | Michael H. Slayton | Methods and systems for fat reduction and/or cellulite treatment |
US8715186B2 (en) | 2009-11-24 | 2014-05-06 | Guided Therapy Systems, Llc | Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy |
US9149658B2 (en) | 2010-08-02 | 2015-10-06 | Guided Therapy Systems, Llc | Systems and methods for ultrasound treatment |
US9504446B2 (en) | 2010-08-02 | 2016-11-29 | Guided Therapy Systems, Llc | Systems and methods for coupling an ultrasound source to tissue |
WO2013009785A2 (en) | 2011-07-10 | 2013-01-17 | Guided Therapy Systems, Llc. | Systems and methods for improving an outside appearance of skin using ultrasound as an energy source |
WO2013012641A1 (en) | 2011-07-11 | 2013-01-24 | Guided Therapy Systems, Llc | Systems and methods for coupling an ultrasound source to tissue |
US9263663B2 (en) | 2012-04-13 | 2016-02-16 | Ardent Sound, Inc. | Method of making thick film transducer arrays |
US9510802B2 (en) | 2012-09-21 | 2016-12-06 | Guided Therapy Systems, Llc | Reflective ultrasound technology for dermatological treatments |
CN113648551A (zh) | 2013-03-08 | 2021-11-16 | 奥赛拉公司 | 用于多焦点超声治疗的装置和方法 |
US10561862B2 (en) | 2013-03-15 | 2020-02-18 | Guided Therapy Systems, Llc | Ultrasound treatment device and methods of use |
CN103342686B (zh) * | 2013-07-02 | 2015-01-14 | 扬州大学 | 2-苯亚甲基-1,3-茚满二酮双键的环氧化新方法 |
SG11201608691YA (en) | 2014-04-18 | 2016-11-29 | Ulthera Inc | Band transducer ultrasound therapy |
CN104151326B (zh) * | 2014-08-14 | 2016-04-27 | 东南大学 | 一种苝二酰亚胺-罗丹明荧光探针及其制备方法和应用 |
CN104817564B (zh) * | 2015-03-31 | 2017-03-22 | 东南大学 | 一种罗丹明‑(4‑二甲基氨乙基氨基‑1,8‑萘二甲酰亚胺)荧光分子及其制备方法和应用 |
MX2018007094A (es) | 2016-01-18 | 2018-11-09 | Ulthera Inc | Dispositivo de ultrasonido compacto que tiene un arreglo de ultrasonido anular perifericamente conectado electricamente a una placa de circuito impreso flexible y un metodo de montaje del mismo. |
FI3981466T3 (fi) | 2016-08-16 | 2023-10-03 | Ulthera Inc | Järjestelmiä ja menetelmiä ihon kosmeettista ultraäänihoitoa varten |
WO2019164836A1 (en) | 2018-02-20 | 2019-08-29 | Ulthera, Inc. | Systems and methods for combined cosmetic treatment of cellulite with ultrasound |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464936A (en) * | 1990-12-21 | 1995-11-07 | Cetus Oncology Corporation | Compositions for identification of papillomavirus replication inhibitors |
US6960429B2 (en) * | 1997-11-12 | 2005-11-01 | Wisconsin Alumni Research Foundation | Inhibition of viral gene activities |
ATE357447T1 (de) * | 2000-12-18 | 2007-04-15 | Boehringer Ingelheim Ca Ltd | Inhibitoren des papilloma-virus |
-
2003
- 2003-02-04 NZ NZ535051A patent/NZ535051A/en unknown
- 2003-02-04 MX MXPA04007705A patent/MXPA04007705A/es not_active Application Discontinuation
- 2003-02-04 DK DK03700788.7T patent/DK1474690T3/da active
- 2003-02-04 CA CA002474205A patent/CA2474205C/en not_active Expired - Fee Related
- 2003-02-04 DE DE60334524T patent/DE60334524D1/de not_active Expired - Lifetime
- 2003-02-04 AU AU2003202390A patent/AU2003202390A1/en not_active Abandoned
- 2003-02-04 WO PCT/CA2003/000155 patent/WO2003067259A1/en active Application Filing
- 2003-02-04 ES ES03700788T patent/ES2352332T3/es not_active Expired - Lifetime
- 2003-02-04 EP EP03700788A patent/EP1474690B1/en not_active Expired - Lifetime
- 2003-02-04 AT AT03700788T patent/ATE484751T1/de active
- 2003-02-04 JP JP2003566558A patent/JP2005517183A/ja active Pending
- 2003-02-05 US US10/358,790 patent/US6825176B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE60334524D1 (de) | 2010-11-25 |
JP2005517183A (ja) | 2005-06-09 |
EP1474690B1 (en) | 2010-10-13 |
CA2474205C (en) | 2009-06-02 |
AU2003202390A1 (en) | 2003-09-02 |
US20030194698A1 (en) | 2003-10-16 |
NZ535051A (en) | 2006-04-28 |
ATE484751T1 (de) | 2010-10-15 |
ES2352332T3 (es) | 2011-02-17 |
WO2003067259A1 (en) | 2003-08-14 |
MXPA04007705A (es) | 2005-07-13 |
US6825176B2 (en) | 2004-11-30 |
EP1474690A1 (en) | 2004-11-10 |
CA2474205A1 (en) | 2003-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1474690T3 (da) | E2-forskydningsassay til identifikation af inhibitorer af HPV | |
ATE475095T1 (de) | Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren | |
DE602005013998D1 (de) | Verfahren und reagenzien zur erkennung von melanomen | |
JP2004503760A5 (da) | ||
ATE556323T1 (de) | Neurofibrilläre marker | |
EP1671118A4 (en) | CYANID PERCEPTIONS AND USES THEREOF | |
CY1107660T1 (el) | Μεθοδοι επισημανσης υλικων | |
RU2011117297A (ru) | Праймеры и зонды для обнаружения вируса папилломы человека и последовательностей бета-глобина человека в исследуемых образцах | |
ATE492565T1 (de) | Immunogene, antikörper und konjugate für ketamin und dessen metaboliten | |
DE50106822D1 (de) | Farbstoffpaare für fluoreszenz-resonanz-energie-transfer (fret) messungen | |
WO2006020933A3 (en) | Dual labeled fluorescent probes | |
DE60120460D1 (de) | Teststab | |
ATE458826T1 (de) | Verfahren zur bestimmung von keimen | |
DE69900465T2 (de) | Ein screeningverfahren, basierend auf fluoreszenzpolarisation | |
DE60113811D1 (de) | NACHWEIS DER BINDUNG VON Ladungsträgern mittels PH- ODER POTENTiaL-SENSITIVEr SONDEN | |
ATE540048T1 (de) | Neurotransmittersensoren und verfahren zu ihrer verwendung | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
ATE466284T1 (de) | Bakterientestverfahren mit bindung einer intrazellularer enzyme | |
ATE478039T1 (de) | Assays für amphetamin und methamphetamin | |
DE602004031571D1 (de) | Enzymhemmungsimmunverfahren | |
WO2001002598A3 (en) | Screening for compounds modulating mitochondrial proton leak | |
DE602006013361D1 (de) | Verfahren zum on-site-drogennachweis bei illegalen drogenproben | |
DE60220168D1 (de) | Verfahren zur identifizierung von hiv rt-dimerisation-inhibitoren | |
JP2001512032A5 (da) | ||
DE60036584D1 (de) | Ein permanentes fluoreszenz-testverfahren |